Furthermore, c-MET establishes a crosstalk pathway with the epidermal growth factor receptor (EGFR) that promotes chemoresistance in HNSCC through the activation of downstream signaling molecules, including RAS, RAF, MEK1, MEK2, and ERK. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.